Propel Bio Management as of Dec. 31, 2024
Portfolio Holdings for Propel Bio Management
Propel Bio Management holds 21 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Plains Gp Holdings Lp-cl Comm (PAGP) | 23.2 | $23M | 1.3M | 18.38 | |
| Madrigal Pharmaceuticals Comm (MDGL) | 13.2 | $13M | 43k | 308.57 | |
| Akero Therapeutics Comm (AKRO) | 9.5 | $9.6M | 344k | 27.82 | |
| Achieve Life Sciences Comm (ACHV) | 8.6 | $8.6M | 2.5M | 3.52 | |
| Applied Therapeutics Comm (APLT) | 8.2 | $8.2M | 9.6M | 0.86 | |
| Phathom Pharmaceuticals I Comm (PHAT) | 8.0 | $8.0M | 990k | 8.12 | |
| Tscan Therapeutics Comm (TCRX) | 6.3 | $6.3M | 2.1M | 3.04 | |
| Avidity Biosciences Comm (RNA) | 5.2 | $5.2M | 179k | 29.08 | |
| Ardelyx Comm (ARDX) | 4.8 | $4.8M | 951k | 5.07 | |
| Abeona Therapeutics Comm (ABEO) | 3.5 | $3.5M | 624k | 5.57 | |
| Syndax Pharmaceuticals In Comm (SNDX) | 2.4 | $2.4M | 183k | 13.22 | |
| Kymera Therapeutics Comm (KYMR) | 2.3 | $2.3M | 56k | 40.23 | |
| Zevra Therapeutics Comm (ZVRA) | 1.5 | $1.5M | 180k | 8.34 | |
| Kura Oncology Comm (KURA) | 1.1 | $1.1M | 130k | 8.71 | |
| Athira Pharma Comm (ATHA) | 0.9 | $876k | 1.5M | 0.59 | |
| Eiger Biopharmaceuticals Comm | 0.8 | $765k | 146k | 5.23 | |
| Jasper Therapeutics Comm (JSPR) | 0.4 | $428k | 20k | 21.38 | |
| Delcath Systems Comm (DCTH) | 0.2 | $205k | 17k | 12.04 | |
| Compass Pathways Comm (CMPS) | 0.1 | $95k | 25k | 3.78 | |
| Maat Pharma Saca Comm (MATPF) | 0.0 | $25k | 3.2k | 7.96 | |
| Chinook Therapeutics Comm | 0.0 | $9.8k | 79k | 0.12 |
